Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Depreciation and Depletion (2019 - 2025)

Historic Depreciation and Depletion for Biodesix (BDSX) over the last 7 years, with Q3 2025 value amounting to $900000.0.

  • Biodesix's Depreciation and Depletion fell 1000.0% to $900000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.7 million, marking a year-over-year increase of 1294.3%. This contributed to the annual value of $3.8 million for FY2024, which is 17992.57% up from last year.
  • As of Q3 2025, Biodesix's Depreciation and Depletion stood at $900000.0, which was down 1000.0% from $900000.0 recorded in Q2 2025.
  • Over the past 5 years, Biodesix's Depreciation and Depletion peaked at $1.0 million during Q3 2024, and registered a low of $200000.0 during Q2 2021.
  • Over the past 5 years, Biodesix's median Depreciation and Depletion value was $422000.0 (recorded in 2022), while the average stood at $561052.6.
  • Its Depreciation and Depletion has fluctuated over the past 5 years, first crashed by 2500.0% in 2023, then skyrocketed by 23333.33% in 2024.
  • Biodesix's Depreciation and Depletion (Quarter) stood at $428000.0 in 2021, then fell by 1.4% to $422000.0 in 2022, then grew by 5.45% to $445000.0 in 2023, then surged by 116.85% to $965000.0 in 2024, then fell by 6.74% to $900000.0 in 2025.
  • Its last three reported values are $900000.0 in Q3 2025, $900000.0 for Q2 2025, and $900000.0 during Q1 2025.